Advancing Cardiovascular Innovation Through Research and Culture with Dr. Mark J. Ricciardi
Becker’s Healthcare PodcastSummary
Leaders in healthcare face significant challenges as they navigate the complexities of managing health systems. At the forefront of this discussion is Mark Ricciardi, Section Chief for Interventional Cardiology and Structural Heart Disease at Endeavor Health, who emphasizes the importance of innovation in cardiovascular medicine. Endeavor Health has gained national recognition for its advancements in interventional cardiovascular techniques, particularly in heart valve disease, which has been a focus since it became one of the first U.S. centers to perform a mitral valve repair via catheter in 2003.
Ricciardi highlights the institution's commitment to participating in clinical trials and developing new technologies, which has positioned them as leaders in the field. Their outcomes research group plays a crucial role in analyzing data and improving clinical practices, contributing to their ranking as the sixth best in the U.S. and ninth globally for research efforts. He notes that while there is a surge in innovation, there remains an opportunity to expand minimally invasive therapies to a broader patient population, rather than limiting them to those who are critically ill.
For healthcare leaders looking to foster innovation, Ricciardi advises creating a supportive culture that prioritizes clinical research alongside patient care. He stresses the need to recognize and reward those passionate about innovation within their organizations and to integrate research efforts into the core mission of healthcare systems. By doing so, institutions can enhance their contributions to the medical community and improve patient outcomes.
Show Notes
In this episode, Mark J. Ricciardi, MD, Section Chief Interventional Cardiology and Structural Heart; Charles Walgreen Jr Chair, Endeavor Health (formerly NorthShore) Cardiovascular Institute; Clinical Prof University of Chicago Pritzker School of Medicine, discusses cardiovascular innovation, minimally invasive valve therapies, clinical trials and the importance of building a culture that prioritizes research alongside clinical care.
More from Becker’s Healthcare Podcast
This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Bryon Frost, MD, ABEM, Vice President And Chief Medical Informatics Officer, McLeod Health, who discusses using AI to reduce information overload, connect fragmented clinical data and support more continuous care across settings.
In this episode, Saurabh Tripathi, EVP and CFO of Ascension, discusses the system’s fiscal 2026 financial turnaround, including improved operating margins, revenue growth, and expanded patient care.
In this episode, Amy Lynn LeDuc, Vice President and GM of Healthcare & Life Sciences, Adobe, discusses how healthcare organizations can use AI to personalize patient engagement, improve access, and streamline communications while maintaining trust. She also shares strategies for moving AI pilots into production, including clear ownership, measurable ROI, cross-functional collaboration, and human-centered change management.
In this episode, William Teague, Managing Director, VMG Health, and Cordell Mack, Managing Director, VMG Health, discuss how private equity investment, reimbursement pressures, and the growth of ambulatory cardiac procedures are reshaping cardiovascular care. They explore strategies for aligning physicians, adapting partnership models, and positioning health systems for long term growth.
In this episode, Alan Condon, Editor-in-Chief at Becker's Healthcare, joins Scott Becker to discuss major healthcare mergers and acquisitions, including Bon Secours Mercy Health’s planned acquisition of Surgery Partners, Kaiser Permanente’s expansion through Risant Health, and the proposed Rush University System for Health and Endeavor Health merger.